Thioredoxin in the Endocrine Response to Stress

Vitamins and Hormones

Volumn 57, Issue C, 1997, Pages 153-175

  Tanaka, Hirotoshi ^a   Makino, Yuichi ^a   Okamoto, Kensaku ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; GLUCOCORTICOID; THIOREDOXIN;

ANIMAL; GENE EXPRESSION; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; REVIEW; STRESS;

ANIMALS; ANTIOXIDANTS; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; OXIDATION-REDUCTION; STRESS; THIOREDOXIN;

EID: 0032602373     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60643-3     Document Type: Article

References (93)

1. Abate C., Patel L., Rauscher III F.J., and Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249 (1990) 1157-1161
2. Akamatsu Y., Ohno T., Hirota K., Kagoshima H., Yodoi J., and Shigesada K. Redox regulation of the DNA binding activity in transcription factor PEBP2. J. Biol. Chem. 272 (1997) 14497-14502
3. Alksnis M., BarkhemStr T., oUmstedt P.-E., Ahola H., Kutoh E., Gustafsson J.-A., Poellinger L., and Nilson S. High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. J. Biol. Chem. 266 (1991) 10078-10085
4. Ammendola R., Mesuraca M., Russo T., and Cimino F. The DNA-binding efficiency of Sp1 is affected by redox changes. Eur. J. Biochem. 225 (1994) 483-489
5. Andersen J.F., Sanders D.A., Gasdaska J.R., Weichsel A., Powis G., and Montfort W.R. Human thioredoxin homodimers: Regulation by pH, role of aspartate 60, and crystal structure of the aspartate 60 → asparagine mutant. Biochemistry 36 (1997) 13979-13988
6. Anderson M.T., Staal F.J.T., Gitler C., and Herzenberg L.A. Separation of oxidant-initiated and redox-regulated step in the NF-κB signal transduction pathway. Proc. Natl. Acad. Sci. USA 91 (1994) 11527-11531
7. Arnone M.I., Zannini M., and Lauro R.D. The DNA binding activity and the dimerization ability of the thyroid transcription factor I are redox regulated. J. Biol. Chem. 270 (1995) 12048-12055
8. Bandyopadhyay S., and Gronostajski R.M. Identification of a conserved oxidation-sensitive cysteine residue in the NFI family of DNA-binding proteins. J. Biol. Chem. 269 (1994) 29949-29955
9. Bauskin A.R., Aikalay I., and Ben-Neriah Y. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell 66 (1991) 685-696
10. Beato M., Herrlich P., and Schütz G. Steroid receptors: Many actors in search of a plot. Cell 83 (1995) 851-857
11. Blake M.J., Udelsman R., Feulner G.J., Norton D.D., and Holbrook N.J. Stress-induced heat shock protein 70 expression in adrenal cortex: An adrenocorticotropic hormone-sensitive, age-dependent response. Proc. Natl. Acad. Sci. USA 88 (1991) 9873-9877
12. Bodwell J.E., Holbrook N.J., and Munck A. Sulfhydryl-modifying reagents reversibly inhibit binding of glucocorticoid-receptor complexes to DNA-cellulose. Biochemistry 23 (1984) 1392-1398
13. Boumpas D.T., Chrousus G.P., Wilder R.L., Cupps T.R., and Balow J.E. NIH conference. Glucocorticoid therapy for immune-mediated diseases: Basis and clinical correlates. Ann. Intern. Med. 119 (1993) 1198-1208
14. Cappel R.E., and Gilbert H.F. Thiol/disulfide exchange between 3-hydroxy-3-methylglutaryl-CoA reductase and glutathione. A thermodynamically facile dithiol oxidation. J. Biol. Chem. 263 (1988) 12204-12212
15. Cato A.C.B., and Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. BioEssays 18 (1996) 371-378
16. Chakraborti P.K., Garabedian M.J., Yamamoto K.R., and Simons Jr. S.S. Role of cysteines 640, 656, and 661 in steroid binding to rat glucocorticoid receptor. J. Biol. Chem. 267 (1992) 11366-11373
17. Chivers P.T., Laboissiere M.C., and Raines R.T. The CXXC motif: Imperatives for the formation of native disulfide bonds in the cell. EMBO J. 15 (1996) 2659-2667
18. Chivers P.T., Prehoda K.E., and Raines R.T. The CXXC motif: A rheostat in the active site. Biochemistry 36 (1997) 4061-4066
19. Cole T.J., Blendy J.A., Monaghan A.P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummller E., Unsicker K., and Schutz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9 (1995) 1608-1621
20. Demple B., and Amabile-Cuevas C.F. Redox redux: The control of oxidative stress responses. Cell 67 (1991) 837-839
21. Dröge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.P., Roth S., and Gmunder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8 (1994) 1131-1138
22. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895
23. Evans R.M., and Hollenberg S.M. Zinc fingers: Guilt by association. Cell 52 (1988) 1-3
24. Frei B. Reactive oxygen species and antioxidant vitamins: Mechanisms of action. Am. J. Med. 97 (1994) 5S-13S Suppl. 3A
25. Fukawa E., Tanaka H., Makino Y., Hirano F., Kawai S., and Makino I. Homologous down-regulation of the glucocorticoid receptor down-modulates cellular hormone responsiveness in human histiocytic lymphoma U937 cells. Endocr. J. 41 (1994) 623-630
26. Gasdaska J.R., Kirkpatrick D.L., Montfort W., Kuperus M., Hill S.R., Berggren M., and Powis G. Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73 → Ser mutation. Biochem. Pharmacol. 52 (1996) 1741-1747
27. Glass K.C. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Mol. Endocrinol. 15 (1994) 391-407
28. Guehmann S., Vorbrueggen G., Kalkbrenner F., and Moelling K. Reduction of a conserved cys is essential for Myb DNA-binding. Nucleic Acids Res. 20 (1992) 2279-2286
29. Hainaut P., and Milner J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53 (1993) 4469-4473
30. Halliwell B., and Gutteridge J.M.C. "Free Radicals in Biology and Medicine,". 2nd ed. (1989), Clarendon Press, Oxford
31. Hayashi S., Hajiro-Nakanishi K., Makino Y., Eguchi H., Yodoi J., and Tanaka H. Functional susceptibility of estrogen receptor by redox change with reference to a role of thioredoxin as a mediator. Nucleic Acids Res. 25 (1997) 4035-4040
32. Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94 (1997) 3633-3638
33. Holmgren A. Thioredoxin. Annu. Rev. Biochem. 54 (1985) 237-271
34. Holmgren A. Thioredoxin structure and mechanism: Conformational changes on oxidation of the active-site sulfhydryls to a disulfide. Structure 3 (1995) 239-243
35. Hörlein A.J., Näär A.M., Heinzel T., Torchis J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Sörerström M., Glass C.K., and Rosenfeld M.G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377 (1995) 397-404
36. Huang R., and Adamson E.D. Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: Evidence for modulation by a redox mechanism. DNA Cell Biol. 12 (1993) 265-273
37. Ireland R.C., Li S.-Y., and Dougherty J.J. The DNA binding of purified Ah receptor heterodimer is regulated by redox conditions. Arch. Biochem. Biophys. 319 (1995) 470-480
38. Jayaraman L., Murthy K.G., Zhu C., Curran T., Xanthoudakis S., and Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11 (1997) 558-570
39. Kaghad M., Dessarps F., Jacquemin-Sablon H., Caput D., Fradelizi D., and Wollman E.E. Genomic cloning of human thioredoxin-encoding gene: Mapping of the transcription start point and analysis of the promoter. Gene 140 (1994) 272-278
40. Kambe F., Nomura Y., Okamoto T., and Seo H. Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Mol. Endocrinol. 10 (1996) 801-812
41. KatzenellenbogenO&apos J.A., Malley B.W., and Katzenellenbogen B.S. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 10 (1996) 119-131
42. Korthuis R.J., and Granger D.N. In: Taylor A.E., Matalon S., and Wrad P.A. (Eds). In "Physiology of Oxygen Radicals" (1986), Williams & Wilkins, Baltimore 217-249
43. Kurooka H., Kato K., Minoguchi S., Takahashi Y., Ikeda J., Habu S., Osawa N., Buchberg M., Moriwaki K., Shisa H., and Honjo T. Cloning and characterization of the nucleoredoxin gene that encodes a novel protein related to thioredoxin. Genomics 39 (1997) 331-339
44. Leppa S., Pirkkala L., Chow S.C., Eriksson J.E., and Sistonen L. Thioredoxin is transcriptionally induced upon activation of heat shock factor 2. J. Biol. Chem. 272 (1997) 30400-30404
45. Lippman M.E., Yarbro G.K., and Leventhal B.G. Clinical implication of glucocorticoid receptors in human leukemia. Cancer Res. 38 (1978) 4251-4256
46. Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., and Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 (1991) 497-505
47. Makino Y., Tanaka H., Dahlman-Wright K., and Makino I. Modulation of glucocorticoid-inducible gene expression by metal ions. Mol. Pharmacol. 49 (1996) 612-620
48. Makino Y., Okamoto K., Yoshikawa N., Kirota K., Yodoi J., Umesono K., Makino I., and Tanaka H. Thioredoxin: A redox-regulating cellular cofactor for glucocorticoid hormone action. J. Clin. Invest. 98 (1996) 2469-2477
49. Makino Y., Yoshikawa N., Okamoto K., Hirota K., Yodoi J., Makino I., and Tanaka H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J. Biol. Chem (1999) in press
50. Malchoff D.M., Brufsky A., Reardon G., McDermott P., Javier E.C., Bergh C.-H., and Rowe D. Mutation of the glucocorticoid receptor in primary cortisol resistance. J. Clin. Invest. 91 (1993) 1918-1925
51. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: The second decade. Cell 83 (1995) 835-839
52. Masutani H., Hirota K., Sasada T., Ueda-Taniguchi Y., Taniguchi Y., Sono H., and Yodoi J. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-1 Tax. Immunol. Lett. 54 (1996) 67-71
53. Matsui M., Oshima M., Oshima H., Takaku K., Maruyama T., Yodoi J., and Taketo M.M. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev. Biol. 178 (1996) 179-185
54. McBride A.A., Klausner R.D., and Howley P.M. Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro. Proc. Natl. Acad. Sci. USA 89 (1992) 7531-7535
55. McCord J.M. Oxygen-derived radicals: A link between reperfusion injury and inflammation. Fed. Proc. 46 (1987) 2402-2406
56. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12 (1993) 2005-2015
57. Miranda-Vizuete A., Gustafsson J.-A., and Spyrou G. Molecular cloning and expression of a cDNA encoding a human thioredoxin-like protein. Biochem. Biophys. Res. Commun. 243 (1998) 284-288
58. Munck A., Guyre P.M., and Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5 (1984) 25-44
59. Myrset A.H., Bostad A., Jamin N., Lirsac P.-N., Toma F., and Gabrielsen O.S. DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein. EMBO J. 12 (1993) 4625-4633
60. Nakamura H., Nakamura K., and Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15 (1997) 351-369
61. Nakshatri H., Bhat-Nakshatri P., and Currie R.A. Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J. Biol. Chem. 271 (1996) 28784-28792
62. Okamoto K., Tanaka H., Makino Y., and Makino I. Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl hydrogen phosphate] potassium salt), via a redox-dependent mechanism. Biochem. Pharmacol. 56 (1998) 79-86
63. Okamoto T., Ogiwara H., Hayashi T., Mitsui A., Kawabe T., and Yodoi J. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol. 4 (1992) 811-819
64. Onate S.A., Tsai S.Y., Tsai M.-J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357
65. Pognonec P., Kato H., and Roeder R.G. The helix-loop-helix repeat transcription factor USF can be functionally regulated in a redox-dependent manner. J. Biol. Chem. 267 (1992) 24563-24567
66. Pratt W.B. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 268 (1993) 21455-21458
67. Qin J., Clore G.M., Kennedy W.M.P., Huth J.R., and Gronenborn A.M. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NFκB. Structure 3 (1995) 297-389
68. Qin J., Clore G.M., Kennedy W.P., Kuszewski J., and Gronenborn A.M. The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal. Stricture 4 (1996) 613-620
69. Rainwater R., Parks D., Anderson M.E., Tegtmeyer P., and Mann K. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol. 15 (1995) 3892-3903
70. Rangarajan P.N., Umesono K., and Evans R.M. Modulation of glucocorticoid receptor function by protein kinase A. Mol. Endocrinol. 6 (1992) 1451-1457
71. Sahaf B., Soderberg A., Spyrou G., Barral A.M., Pekkari K., Holmgren A., and Rosen A. Thioredoxin expression and localization in human cell lines: Detection of full-length and truncated species. Exp. Cell Res. 236 (1997) 181-192
72. Schenk H., Klein M., Erdbrugger W., Droge W., and Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA 91 (1994) 1672-1676
73. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10 (1991) 2247-2258
74. Schreck R., Albermann K., and Baeuerle P.A. Nuclear factor κB: An oxidative stress-responsive transcription factor of eukaryotic cells. Free Radic. Res. Commun. 17 (1992) 221-237
75. Selye H. The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol. Metab. 6 (1946) 117-230
76. Simons Jr. S.S., and Pratt W.B. Glucocorticoid receptor thiols and steroid-binding activity. Methods Enzymol. 251 (1995) 406-422
77. Snyder G.H., Cennerazzo M.J., Karalis A.J., and Field D. Electrostatic influence of local cysteine environments on disulfide exchange kinetics. Biochemistry 20 (1981) 6509-6518
78. Spyrou G., Enmark E., Miranda-Vizuete A., and Gustafsson J.-A. Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 272 (1997) 2936-2941
79. Storz G., Tartaglia L.A., and Ames B.N. Transcriptional regulation of oxidative stress-inducible genes: Direct activation by oxidation. Science 248 (1990) 189-194
80. Tanaka H., Akama H., Ichikawa Y., Homma M., and Oshima H. Glucocorticoid receptors in normal human leukoyctes: Effects of age, gender, seasons, and plasma cortisol concentrations. Clin. Chem. 37 (1991) 1715-1719
81. Tanaka H., Dong Y., McGuire J., Okret S., Poellinger L., Makino I., and Gustafsson J.-A. The glucocorticoid receptor and a putative repressor protein coordinately modulate glucocorticoid responsiveness of the mouse mammary tumor virus promoter in the rat hepatoma cell line M1.19. J. Biol. Chem. 268 (1993) 1854-1859
82. Taniguchi Y., Taniguchi-Ueda Y., Mori K., and Yodoi J. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res. 24 (1996) 2746-2752
83. Toledano M.B., and Leonard W.J. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88 (1991) 4328-4332
84. Toledano M.B., Kullik I., Trinh F., Baird P.T., Schneider T.D., and Storz G. Redox-dependent shift of OxyR-DNA contacts along an extended DNA-binding site: A mechanism for differential promoter selection. Cell 78 (1994) 897-909
85. Vanderbilt J.N., Miesfeld R., Maler B.A., and Yamamoto K.R. Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol. Endocrinol. 1 (1987) 68-74
86. Verhaegh G.W., Richard M.-J., and Hainaut P. Regulation of p53 by metal ions and by antioxidants: Dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Mol. Cell. Biol. 17 (1997) 5699-5706
87. Wasylyk C., and Wasylyk B. Oncogenic conversion of Ets affects redox regulation in vivo and in vitro. Nucleic Acids Res. 21 (1993) 523-529
88. Weichsel A., Gasdaska J.R., Powis G., and Montfort W.R. Crystal structures of reduced, oxidized, and mutated human thioredoxins: Evidence for a regulatory homodimer. Structure 4 (1996) 735-751
89. Wollman E.E., Kahan A., and Fradelizi D. Detection of membrane associated thioredoxin on human cells lines. Biochem. Biophys. Res. Commun. 230 (1997) 602-606
90. Wu X., Bishopric N.H., Discher D.J., Murphy B.J., and Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol. 16 (1996) 1035-1046
91. Xanthoudakis S., Miao G., Wang F., Pan Y.E., and Curran T. Redox activation of Fos-Jun binding activity is mediated by a DNA repair enzyme. EMBO J. 11 (1992) 3323-3335
92. Xanthoudakis S., Miao G.G., and Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc. Natl. Acad. Sci. USA 91 (1994) 23-27
93. Yu B.P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74 (1994) 139-162